Deborah Lehmann

Dr

  • The University of Western Australia (M561), 35 Stirling Highway,

    6009 Perth

    Australia

  • 1430 Citations
  • 22 h-Index
20022019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Deborah Lehmann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Western Australia Medicine & Life Sciences
Pneumococcal Vaccines Medicine & Life Sciences
Conjugate Vaccines Medicine & Life Sciences
Papua New Guinea Medicine & Life Sciences
Otitis Media Medicine & Life Sciences
Moraxella (Branhamella) catarrhalis Medicine & Life Sciences
Streptococcus pneumoniae Medicine & Life Sciences
vaccines Agriculture & Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

  • 1430 Citations
  • 22 h-Index
  • 73 Article
  • 7 Letter
  • 4 Review article
  • 1 Other chapter contribution
Open Access
otitis media
Otitis Media
cohort studies
linkage (genetics)
Hospitalization
1 Citation (Scopus)

Immunogenicity and immune memory after a pneumococcal polysaccharide vaccine booster in a high-risk population primed with 10-valent or 13-valent pneumococcal conjugate vaccine: A randomized controlled trial in Papua New Guinean children

van den Biggelaar, A. H. J., Pomat, W. S., Masiria, G., Wana, S., Nivio, B., Francis, J., Ford, R., Passey, M., Kirkham, L. A., Jacoby, P., Lehmann, D. & Richmond, P., 4 Feb 2019, In : Vaccines. 7, 1, 17.

Research output: Contribution to journalArticle

Open Access
Conjugate Vaccines
Pneumococcal Vaccines
Randomized Controlled Trials
Population
Pneumococcal Infections
Western Australia
Gastroenteritis
Hospitalization
Cohort Studies
Rotavirus Vaccines
4 Citations (Scopus)

Safety and immunogenicity of pneumococcal conjugate vaccines in a high-risk population: A randomized controlled trial of 10-valent and 13-valent pneumococcal conjugate vaccine in Papua New Guinean infants

Pomat, W. S., Van Den Biggelaar, A. H. J., Wana, S., Francis, J. P., Solomon, V., Greenhill, A. R., Ford, R., Orami, T., Passey, M., Jacoby, P., Kirkham, L. A., Lehmann, D. & Richmond, P. C., 1 May 2019, In : Clinical Infectious Diseases. 68, 9, p. 1472-1481 10 p.

Research output: Contribution to journalArticle

Open Access
Conjugate Vaccines
Pneumococcal Vaccines
Randomized Controlled Trials
Safety
Population
4 Citations (Scopus)

Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: A protocol for a prospective observational study

Chan, J., Nguyen, C. D., Lai, J. Y. R., Dunne, E. M., Andrews, R., Blyth, C. C., Datta, S., Fox, K., Ford, R., Hinds, J., La Vincente, S., Lehmann, D., Lim, R., Mungun, T., Newton, P. N., Phetsouvanh, R., Pomat, W. S., Xeuatvongsa, A., Von Mollendorf, C., Dance, D. A. B. & 3 othersSatzke, C., Muholland, K. & Russell, F. M., 1 May 2018, In : BMJ Open. 8, 5, e021512.

Research output: Contribution to journalArticle

Open Access
Conjugate Vaccines
Pneumococcal Vaccines
Observational Studies
Vaccines
Prospective Studies

Projects 2004 2019